These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20363623)

  • 1. Squalenoyl nucleoside monophosphate nanoassemblies: new prodrug strategy for the delivery of nucleotide analogues.
    Caron J; Reddy LH; Lepêtre-Mouelhi S; Wack S; Clayette P; Rogez-Kreuz C; Yousfi R; Couvreur P; Desmaële D
    Bioorg Med Chem Lett; 2010 May; 20(9):2761-4. PubMed ID: 20363623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemcitabine-based therapy for pancreatic cancer using the squalenoyl nucleoside monophosphate nanoassemblies.
    Maksimenko A; Caron J; Mougin J; Desmaële D; Couvreur P
    Int J Pharm; 2015 Mar; 482(1-2):38-46. PubMed ID: 25448549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-HIV efficacy and biodistribution of nucleoside reverse transcriptase inhibitors delivered as squalenoylated prodrug nanoassemblies.
    Hillaireau H; Dereuddre-Bosquet N; Skanji R; Bekkara-Aounallah F; Caron J; Lepêtre S; Argote S; Bauduin L; Yousfi R; Rogez-Kreuz C; Desmaële D; Rousseau B; Gref R; Andrieux K; Clayette P; Couvreur P
    Biomaterials; 2013 Jul; 34(20):4831-8. PubMed ID: 23562054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel nanoassemblies composed of squalenoyl-paclitaxel derivatives: synthesis, characterization, and biological evaluation.
    Dosio F; Reddy LH; Ferrero A; Stella B; Cattel L; Couvreur P
    Bioconjug Chem; 2010 Jul; 21(7):1349-61. PubMed ID: 20597546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Squalenoyl nanomedicines as potential therapeutics.
    Couvreur P; Stella B; Reddy LH; Hillaireau H; Dubernet C; Desmaële D; Lepêtre-Mouelhi S; Rocco F; Dereuddre-Bosquet N; Clayette P; Rosilio V; Marsaud V; Renoir JM; Cattel L
    Nano Lett; 2006 Nov; 6(11):2544-8. PubMed ID: 17090088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Freeze-drying of squalenoylated nucleoside analogue nanoparticles.
    Bildstein L; Hillaireau H; Desmaële D; Lepêtre-Mouelhi S; Dubernet C; Couvreur P
    Int J Pharm; 2009 Nov; 381(2):140-5. PubMed ID: 19782881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bis(benzoyloxybenzyl)-DiPPro nucleoside diphosphates of anti-HIV active nucleoside analogues.
    Weinschenk L; Gollnest T; Schols D; Balzarini J; Meier C
    ChemMedChem; 2015 May; 10(5):891-900. PubMed ID: 25847660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of phosphorodiamidate prodrugs of antiviral and anticancer nucleosides.
    McGuigan C; Bourdin C; Derudas M; Hamon N; Hinsinger K; Kandil S; Madela K; Meneghesso S; Pertusati F; Serpi M; Slusarczyk M; Chamberlain S; Kolykhalov A; Vernachio J; Vanpouille C; Introini A; Margolis L; Balzarini J
    Eur J Med Chem; 2013; 70():326-40. PubMed ID: 24177359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of an amphiphilic squalenoyl prodrug of gemcitabine with cellular membranes.
    Bildstein L; Pili B; Marsaud V; Wack S; Meneau F; Lepêtre-Mouelhi S; Desmaële D; Bourgaux C; Couvreur P; Dubernet C
    Eur J Pharm Biopharm; 2011 Nov; 79(3):612-20. PubMed ID: 21784150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interfacial behavior of PEGylated lipids and their effect on the stability of squalenoyl-drug nanoassemblies.
    Bekkara-Aounallah F; Ambike A; Gref R; Couvreur P; Rosilio V
    Int J Pharm; 2014 Aug; 471(1-2):75-82. PubMed ID: 24811925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A unique multidrug nanomedicine made of squalenoyl-gemcitabine and alkyl-lysophospholipid edelfosine.
    Rodríguez-Nogales C; Sebastián V; Irusta S; Desmaële D; Couvreur P; Blanco-Prieto MJ
    Eur J Pharm Biopharm; 2019 Nov; 144():165-173. PubMed ID: 31546021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-conjugated nucleoside monophosphate and monophosphonate prodrugs: A versatile drug delivery paradigm.
    Zhang Y; Fan C; Zhang J; Tian X; Zuo W; He K
    Eur J Med Chem; 2024 Sep; 275():116614. PubMed ID: 38925014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the antitumor activity of squalenoyl-paclitaxel conjugate nanoassemblies by manipulating the linker between paclitaxel and squalene.
    Caron J; Maksimenko A; Wack S; Lepeltier E; Bourgaux C; Morvan E; Leblanc K; Couvreur P; Desmaële D
    Adv Healthc Mater; 2013 Jan; 2(1):172-85. PubMed ID: 23213041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prodrugs of Nucleoside Triphosphates as a Sound and Challenging Approach: A Pioneering Work That Opens a New Era in the Direct Intracellular Delivery of Nucleoside Triphosphates.
    Camarasa MJ
    ChemMedChem; 2018 Sep; 13(18):1885-1889. PubMed ID: 30152096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. γ-Non-Symmetrically Dimasked TriPPPro Prodrugs as Potential Antiviral Agents against HIV.
    Zhao C; Jia X; Schols D; Balzarini J; Meier C
    ChemMedChem; 2021 Feb; 16(3):499-512. PubMed ID: 33089929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological activity of modified thiopyrimidine nucleosides.
    Attia AM; Sallam MA; Almehdi AA; Abbasi MM
    Nucleosides Nucleotides; 1999 Oct; 18(10):2307-15. PubMed ID: 10616732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane-permeable Triphosphate Prodrugs of Nucleoside Analogues.
    Gollnest T; Dinis de Oliveira T; Rath A; Hauber I; Schols D; Balzarini J; Meier C
    Angew Chem Int Ed Engl; 2016 Apr; 55(17):5255-8. PubMed ID: 27008042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoenzymatic syntheses and anti-HIV-1 activity of glucose-nucleoside conjugates as prodrugs.
    Rodríguez-Pérez T; Fernández S; Sanghvi YS; Detorio M; Schinazi RF; Gotor V; Ferrero M
    Bioconjug Chem; 2010 Dec; 21(12):2239-49. PubMed ID: 21077659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoassemblies containing a fluorouracil/zidovudine glyceryl prodrug with phospholipase A2-triggered drug release for cancer treatment.
    Jin Y; Yang F; Du L
    Colloids Surf B Biointerfaces; 2013 Dec; 112():421-8. PubMed ID: 24036626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetoresponsive squalenoyl gemcitabine composite nanoparticles for cancer active targeting.
    Arias JL; Reddy LH; Couvreur P
    Langmuir; 2008 Jul; 24(14):7512-9. PubMed ID: 18540685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.